Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.
about
Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of ViewDetermination of Pain Phenotypes in Knee Osteoarthritis: A Latent Class Analysis Using Data From the Osteoarthritis Initiative.Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatmentRisk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population.Developments for improved diagnosis of bacterial bloodstream infections.Soluble urokinase-type plasminogen activator receptor levels in patients with schizophreniaAssociation between routine laboratory tests and long-term mortality among acutely admitted older medical patients: a cohort studyAssessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort studyIntroduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trial.Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels.Diagnostic and prognostic markers in sepsis.Barriers and facilitators for implementing a new screening tool in an emergency department: A qualitative study applying the Theoretical Domains Framework.Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years.High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe disease development in patients with pneumococcal pneumonia.Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia.Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.Cigarette Smoke and the Induction of Urokinase Plasminogen Activator Receptor In Vivo: Selective Contribution of Isoforms to Bronchial Epithelial Phenotype.Biomarkers of sepsis.Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Is Not Associated with Neurological Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.The intriguing role of soluble urokinase receptor in inflammatory diseases.Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.Plasma suPAR is lowered by smoking cessation: a randomized controlled study.Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation.Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)
P2860
Q26738374-01F8358D-5BA8-450B-9FA9-56EA9095B172Q30998667-D25F8D80-C583-432E-9DCB-3544EBC8FA4CQ34399577-CBA5B003-5363-468D-B043-362D748BABB4Q34722262-054FB514-7FE8-4C86-8B9E-93C1E7B9077DQ35171979-69A8EC6F-6B02-47EA-BD9A-8E43E870C946Q35369617-E1E87712-966F-41C6-97B8-6368F3709A47Q36294512-BD915470-A584-47DA-BA8E-17156AD5C91DQ36496226-DBB081A5-640B-495C-B0F8-52D45633652BQ37154114-567154CF-BBB9-484C-B342-42B270458F18Q37471630-4A3097E1-AB11-4425-B677-53287D0ED268Q37503726-7BFFA0D0-70D4-4754-9858-32213FCDFD0FQ38086336-CC7B670C-0AE8-4690-9D05-B0D63F4E8868Q39702668-316CB014-5040-4EC2-81B2-DD51247FD70BQ40216229-CE901155-672C-4115-B5D2-71510D9A9419Q40261498-0AD9C29A-883A-4F67-80A8-C4A3263451EFQ40274048-883545B6-BE60-4D7D-8D26-658F1B011E5BQ40978037-57965FDC-50FE-4B8C-B0C9-1970633EF034Q41559739-94DBB873-9AF3-49CA-AAEF-1EF51D286F23Q41608839-96CB2450-074A-4057-8682-A030F350FB54Q42220979-12F32E8A-98E8-4851-A096-66F1F3BE3A06Q42291229-6075655D-02FC-4733-B396-AAE7154EFBD2Q43490218-6C9EC772-058F-4854-8154-B8D68720B887Q47698573-403926CB-5C34-40E4-AA13-780B754D6389Q49124480-0D7691C2-6AF1-47C6-B9F4-823D793C6F55Q51723464-3FC480E6-EFE7-4734-82A4-70F02AB555B2Q53202443-157703AC-7199-4AAA-A6D8-136A027C0BC3Q53687325-D98A6803-DC4C-4170-9477-4C410ADB223DQ54220908-965F93E8-B8C6-4C9E-A1D3-B562D42D3A33Q55363223-542E531F-6E30-4A58-93F2-27A59AA457D6Q55489498-15219810-4418-49B6-93B4-6E606B4C5170Q58698914-35DEC863-AFC0-4241-89D9-DDA8FC11E8ED
P2860
Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasma suPAR levels are associ ...... ospective observational study.
@ast
Plasma suPAR levels are associ ...... ospective observational study.
@en
type
label
Plasma suPAR levels are associ ...... ospective observational study.
@ast
Plasma suPAR levels are associ ...... ospective observational study.
@en
prefLabel
Plasma suPAR levels are associ ...... ospective observational study.
@ast
Plasma suPAR levels are associ ...... ospective observational study.
@en
P2093
P2860
P50
P356
P1433
P1476
Plasma suPAR levels are associ ...... ospective observational study.
@en
P2093
Gertrude Ellekilde
Henrik Hedegaard Klausen
Janne Petersen
P2860
P2888
P356
10.1186/CC11434
P577
2012-07-23T00:00:00Z
P5875
P6179
1005975447